Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Minimal Pharmacophore for Silent Agonism of the α7 Nicotinic Acetylcholine Receptor
Roger L. Papke, Kinga Chojnacka, Nicole A. Horenstein
Journal of Pharmacology and Experimental Therapeutics (2014) Vol. 350, Iss. 3, pp. 665-680
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Nicotinic Activity of Arecoline, the Psychoactive Element of "Betel Nuts", Suggests a Basis for Habitual Use and Anti-Inflammatory Activity
Roger L. Papke, Nicole A. Horenstein, Clare Stokes
PLoS ONE (2015) Vol. 10, Iss. 10, pp. e0140907-e0140907
Open Access | Times Cited: 116
Identification and Characterization of a G Protein-binding Cluster in α7 Nicotinic Acetylcholine Receptors
Justin R. King, Jacob C. Nordman, Samuel P. Bridges, et al.
Journal of Biological Chemistry (2015) Vol. 290, Iss. 33, pp. 20060-20070
Open Access | Times Cited: 97
Nicotinic acetylcholine receptors: Conventional and unconventional ligands and signaling
Roger L. Papke, Jon Lindstrom
Neuropharmacology (2020) Vol. 168, pp. 108021-108021
Open Access | Times Cited: 92
New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs
Deniz Bağdaş, Mine Sibel Gurun, Pamela Flood, et al.
Current Neuropharmacology (2018) Vol. 16, Iss. 4, pp. 415-425
Open Access | Times Cited: 85
Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors
Roger L. Papke, Nicole A. Horenstein
Pharmacological Reviews (2021) Vol. 73, Iss. 3, pp. 1118-1149
Open Access | Times Cited: 58
Looking below the surface of nicotinic acetylcholine receptors
Clare Stokes, Millet Treinin, Roger L. Papke
Trends in Pharmacological Sciences (2015) Vol. 36, Iss. 8, pp. 514-523
Open Access | Times Cited: 87
The α7 nicotinic receptor dual allosteric agonist and positive allosteric modulator GAT107 reverses nociception in mouse models of inflammatory and neuropathic pain
Deniz Bağdaş, Jenny L. Wilkerson, Abhijit Kulkarni, et al.
British Journal of Pharmacology (2016) Vol. 173, Iss. 16, pp. 2506-2520
Open Access | Times Cited: 66
Silent agonists for α7 nicotinic acetylcholine receptors
Roger L. Papke, Marta Quadri, Alican Gulsevin
Pharmacological Research (2023) Vol. 190, pp. 106736-106736
Open Access | Times Cited: 14
Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation
Nicole A. Horenstein, Roger L. Papke, Abhijit Kulkarni, et al.
Journal of Biological Chemistry (2016) Vol. 291, Iss. 10, pp. 5049-5067
Open Access | Times Cited: 44
Anti-inflammatory Silent Agonists
Nicole A. Horenstein, Roger L. Papke
ACS Medicinal Chemistry Letters (2017) Vol. 8, Iss. 10, pp. 989-991
Open Access | Times Cited: 41
Cholinergic Targets in Lung Cancer
Eliot R. Spindel
Current Pharmaceutical Design (2016) Vol. 22, Iss. 14, pp. 2152-2159
Open Access | Times Cited: 39
Conopeptides [V11L;V16D]ArIB and RgIA4: Powerful Tools for the Identification of Novel Nicotinic Acetylcholine Receptors in Monocytes
Veronika Grau, Katrin Richter, Arik J. Hone, et al.
Frontiers in Pharmacology (2019) Vol. 9
Open Access | Times Cited: 36
Sulfonium Moieties as Ammonium Bioisosteres: Novel Ligands for the Alpha7 Nicotinic Acetylcholine Receptor
Claudio Papotto, Clare Stokes, Carlo Matera, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Two Novel α7 Nicotinic Acetylcholine Receptor Ligands: In Vitro Properties and Their Efficacy in Collagen-Induced Arthritis in Mice
Marjolein A. van Maanen, Roger L. Papke, Frieda A. Koopman, et al.
PLoS ONE (2015) Vol. 10, Iss. 1, pp. e0116227-e0116227
Open Access | Times Cited: 39
Cracking the Betel Nut: Cholinergic Activity of Areca Alkaloids and Related Compounds
Nicole A. Horenstein, Marta Quadri, Clare Stokes, et al.
Nicotine & Tobacco Research (2017) Vol. 21, Iss. 6, pp. 805-812
Open Access | Times Cited: 39
A Human-Specific α7-Nicotinic Acetylcholine Receptor Gene in Human Leukocytes: Identification, Regulation and the Consequences of CHRFAM7A Expression
Todd W. Costantini, Xitong Dang, Maryana V Yurchyshyna, et al.
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 323-336
Open Access | Times Cited: 37
Dissection of N,N-diethyl-N′-phenylpiperazines as α7 nicotinic receptor silent agonists
Marta Quadri, Roger L. Papke, Nicole A. Horenstein
Bioorganic & Medicinal Chemistry (2015) Vol. 24, Iss. 2, pp. 286-293
Open Access | Times Cited: 34
Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states
Roger L. Papke, Clare Stokes, M. Imad Damaj, et al.
British Journal of Pharmacology (2017) Vol. 175, Iss. 11, pp. 1838-1854
Open Access | Times Cited: 32
The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice
Giulia Donvito, Deniz Bağdaş, Wisam Toma, et al.
Experimental Neurology (2017) Vol. 295, pp. 194-201
Open Access | Times Cited: 25
Macroscopic and Microscopic Activation of α7 Nicotinic Acetylcholine Receptors by the Structurally Unrelated Allosteric Agonist-Positive Allosteric Modulators (ago-PAMs) B-973B and GAT107
Marta Quadri, Sumanta Garai, Ganesh A. Thakur, et al.
Molecular Pharmacology (2018) Vol. 95, Iss. 1, pp. 43-61
Open Access | Times Cited: 24
GAT107-mediated α7 nicotinic acetylcholine receptor signaling attenuates inflammatory lung injury and mortality in a mouse model of ventilator-associated pneumonia by alleviating macrophage mitochondrial oxidative stress via reducing MnSOD-S-glutathionylation
Alex Gauthier, Mosi Lin, Sidorela Zefi, et al.
Redox Biology (2023) Vol. 60, pp. 102614-102614
Open Access | Times Cited: 7
Dual effects of supplemental oxygen on pulmonary infection, inflammatory lung injury, and neuromodulation in aging and COVID-19
Mosi Lin, Maleka T. Stewart, Sidorela Zefi, et al.
Free Radical Biology and Medicine (2022) Vol. 190, pp. 247-263
Open Access | Times Cited: 12
The Antinociceptive and Anti-Inflammatory Properties of the α7 nAChR Weak Partial Agonist p-CF3N,N-diethyl-N′-phenylpiperazine
Marta Quadri, Deniz Bağdaş, Wisam Toma, et al.
Journal of Pharmacology and Experimental Therapeutics (2018) Vol. 367, Iss. 2, pp. 203-214
Open Access | Times Cited: 17
α-conotoxin MrIC is a biased agonist at α7 nicotinic acetylcholine receptors
Alexander Mueller, Hana Starobova, Marco Inserra, et al.
Biochemical Pharmacology (2015) Vol. 94, Iss. 2, pp. 155-163
Closed Access | Times Cited: 16
Behavioral and Molecular Basis of Cholinergic Modulation of Pain: Focus on Nicotinic Acetylcholine Receptors
Wisam Toma, Esad Ulker, Mashael Alqasem, et al.
Current topics in behavioral neurosciences (2020), pp. 153-166
Closed Access | Times Cited: 16
Page 1 - Next Page

Scroll to top